Netarsudil Mesylate

Generic Name: netarsudil mesylate

Over-the-Counter (OTC)

Dosage form: POWDER. Active ingredients: NETARSUDIL MESYLATE (1 g/g). Category: BULK INGREDIENT.

Overview

Dosage form: POWDER. Active ingredients: NETARSUDIL MESYLATE (1 g/g). Category: BULK INGREDIENT.

Dosage

Available as powder.

Related Medications

Allium Sativum, Arsenicum Album, Benzoicum Acidum, Berberis Vulgaris, Betula Verrucosa, Calcarea Carbonica, Carbolicum Acidum, Chelidonium Majus, Chlorinum, Citricum Acidum, Histaminum, Ichthyolum, Juniperus Communis, Lycopodium Clavatum, Mercurius Solubilis, Natrum Bicarbonicum, Sodium Hypochlorite, Solidago Virgaurea, Sulphur

allium sativum, arsenicum album, benzoicum acidum, berberis vulgaris, betula verrucosa, calcarea carbonica, carbolicum acidum, chelidonium majus, chlorinum, citricum acidum, histaminum, ichthyolum, juniperus communis, lycopodium clavatum, mercurius solubilis, natrum bicarbonicum, sodium hypochlorite, solidago virgaurea, sulphur

Calculi Dissolution Agent [EPC]

For temporary relief of minor: headache* fatigue* swollen tonsils* nausea* dizziness* itching* coughing* burning pains* *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Brimonidine Tartrate Ophthalmic Solution, 0.15%

brimonidine tartrate ophthalmic solution, 0.15%

11 DESCRIPTION Brimonidine tartrate ophthalmic solution 0.15%, sterile, is a relatively selective alpha-2 adrenergic receptor agonist (topical intraocular pressure lowering agent). The structural formula of brimonidine tartrate is: 5-bromo-6-(2-imidazolidinylideneamino) quinoxaline L-tartrate; MW= 442.24 In solution, brimonidine tartrate ophthalmic solution has a clear, greenish-yellow color. It has an osmolality of 250-350 mOsmol/kg and a pH of 6.6-7.4.

Burn Relief

burn relief

Amide Local Anesthetic [EPC]

Purpose External analgesic

Medical Disclaimer

This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.